Updated date - Oct 21, 2019

[203 Pages Report] The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

Market Dynamics

Growing drug and alcohol consumption

Drug abuse and alcohol consumption are increasing across the globe. According to the United Nations Office on Drugs and Crime (UNODC), in 2015, about 5% of the global adult population consumed drugs at least once. Also, 0.6% of the global adult population suffers from drug use disorders. The extent of harm caused by drugs is equal to losing 28 million years of �healthy� life (disability-adjusted life years [DALYs]), globally. Of these, 17 million were primarily due to morbidity and mortality resulting from various types of drugs. To curb the menace of drug and alcohol abuse, authorities in various countries are focusing on implementing comprehensive drug and alcohol testing measures. Thus, the demand for drug and alcohol testing is expected to increase in the coming years.

Ban on alcohol consumption in several Islamic countries

Consumption of alcohol by the Muslim population is banned in Islamic countries, such as Pakistan, Afghanistan, Bahrain, Libya, Iran, UAE (Emirate of Sharjah), Kuwait, and Yemen. Alcohol consumption in these regions is a punishable offense and the offenders face harsh punishments. For instance, in Afghanistan, it is illegal to purchase alcohol. Similarly, in Iran, very strict laws have been implemented against the consumption of alcohol. As per Article 265 of the new Islamic Penal Code implemented in 2013, drinking alcohol is punishable by 80 lashes, irrespective of the gender of the offender. Also in some cases, the offender may be sentenced to death. Owing to religious regions, coupled with such strict punishments and stringent regulations, the consumption of alcohol in many Islamic countries is very less. This is a major restraint for the growth of the drug and alcohol testing market, especially the breathalyzers market in these countries.

Emergence of fingerprint-based drug screening

Globally, the prevalence of illegal consumption of drugs, such as cannabis, opioids, opiates, cocaine, amphetamines, and ecstasy is on the rise. The annual prevalence of the use of these drugs was 3.6% of the total adult population in 2011 and increased to 5.3% in 2015 (source: United Nations Office on Drugs and Crime). This growing burden of drug addiction creates the need to develop technologically advanced products for drug screening.

Fingerprint-based drug testing is a relatively new concept. It is non-invasive, less time consuming, portable, hygienic, user-friendly, and requires no specific preparation for sample collection and handling. This test is very easy to implement whenever and wherever it is required, thus offering flexible and effective means of supporting workplace drug testing policies. This test works by analyzing the small traces of sweat in the fingerprint to detect drug and drug metabolites. This test is used in workplaces, criminal justice and law enforcement agencies, and drug rehabilitation programs.

Currently, the market for fingerprint-based drug testing is at its infancy stage and is expected to grow at a slower pace compared to other drug testing samples. Intelligent Fingerprint (UK) is the first player to gain entry into this market. In September 2017, the company launched its fingerprint-based drug screening system (consists of the sample collection cartridge and reader analyzer 1000 analysis unit), which is the only product of its kind available in the market. This system can simultaneously screen 4 main drug groups�cocaine, opiates, amphetamines, and cannabis�within 10 minutes of sample collection. If this test is widely adopted, it is expected to replace urine, hair, and blood-based drug tests. This is a significant opportunity for the market players to capitalize on in the drug screening market.

The objectives of this study are as follows:

To define, describe, segment, and forecast the global market by product and service, sample type, end user, and region To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges, and market-specific trends)

To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of competitive landscape for market leaders

To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). To profile key players and comprehensively analyze their market shares and core competencies

To track and analyze competitive developments such as agreements, partnerships, and collaborations; acquisitions; product launches and approvals; expansions; and R&D activities in the global market.

Research Methodology

The study estimates the drug screening market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the market. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

To know about the assumptions considered for the study, download the pdf brochure

The drug screening market is highly competitive with the presence of several big and small players. Prominent players offering products for drug screening include Alere (US), Thermo Fisher (US), Dr�gerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). On the other hand, LabCorp (US), Quest Diagnostics (US), Omega Laboratories (US), Psychemedics (US), CRL (US), SureHire (Canada), and CannAmm (Canada), are key players in the market.

Target Audience for this Report:

Drug and alcohol testing laboratories

Drug and alcohol testing product manufacturing companies

Rapid drug screening device manufacturers

Law enforcement agencies

Healthcare providers

Government agencies

Research and consulting firms

Venture capitalists

Scope of the Report : Drug Screening Market

This report categorizes the market into following segments and subsegments:

By Product & Services

Drug Screening Products Analytical Instruments Immunoanalyzers Chromatography Instruments Breathalyzers Fuel-cell breathalyzer Semi-conductor breathalyzer Other breathalyzers Rapid Testing Devices Urine testing device Drug testing cups Dip cards Drug Testing Cassettes Oral Fluid Testing Devices Consumables Assay Kits Sample Collection devices Calibrators & Controls *Other consumables

Drug Screening Services

By Sample Type

Urine

Breath

Oral Fluid

Hair

Other Samples

By End User

Workplace

Criminal Justice Systems and Law Enforcement Agencies

Drug Treatment Centers

Pain Management Centers

Schools and Colleges

Hospitals

Individual users

Drug testing laboratories

By Region

North America US Canada

Europe Germany UK France RoE

Asia Pacific

Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs.

The following customization options are available for this report.

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Product Analysis

Product Matrix, which gives a detailed comparison of product portfolios of the top companies

The global drug screening market is projected to reach USD 8.63 Billion by 2022 from USD 5.32 Billion in 2017, at a CAGR of 10.2%. Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals and new product & service launches are driving the growth of the market.

The report segments the global market by product and service, sample type, end user, and region.

Based on product, the market is segmented into analytical instruments, rapid testing devices, and consumables. Rapid testing devices market is further subsegmented into urine testing devices and oral fluid testing devices. The urine testing devices segment is expected to account for the largest market share in 2017. However, the oral fluid testing devices segment is projected to register highest CAGR during the forecast period. The high growth in this segment is attributed to the benefits it offers such as shorter detection window, non-invasive nature, and low risk of sample tampering.

The global market by sample type is segmented into urine, breath, oral fluid, hair, and other samples. The urine sample segment is estimated to account for the largest share in 2017, however, the oral fluid samples segment is expected to register the highest growth rate during the forecast period.

Based on end users, the market is segmented into workplaces, criminal justice systems and law enforcement, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories. In 2017, the workplace testing segment is expected to account for the largest share of the market. The growth of this end-user segment can be attributed to the growing safety concerns in the workplace and the increasing number of organizations that have made regular drug screening mandatory.

The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW). The dominance of the North American market is attributed to factors such as rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption.

While the market represents significant growth opportunities, market growth may be hindered due to prohibition of drug testing at workplace in certain regions, and ban on alcohol consumption in Islamic countries. The Drug Screening Market is highly competitive with presence of several big and small players. Prominent players offering drug screening products include Alere (US), Thermo Fisher (US), Dr�gerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). While, LabCorp (US), Quest Diagnostics (US), Omega Laboratories (US), Psychemedics (US), CRL (US), SureHire (Canada), and CannAmm (Canada) are some of key players offering drug screening services.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst